Lexaria Bioscience Corp. (LEXX)
NASDAQ: LEXX
· Real-Time Price · USD
0.80
0.00 (0.13%)
At close: Aug 15, 2025, 3:59 PM
0.82
2.44%
After-hours: Aug 15, 2025, 04:00 PM EDT
Lexaria Bioscience Cash Flow Statement
Financials in USD. Fiscal
year is
September - August.
| Fiscal Year | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | May 31, 2025 | Feb 28, 2025 | Nov 30, 2024 | Aug 31, 2024 | May 31, 2024 | Feb 29, 2024 | Nov 30, 2023 | Aug 31, 2023 | May 31, 2023 | Feb 28, 2023 | Nov 30, 2022 | Aug 31, 2022 | May 31, 2022 | Feb 28, 2022 | Nov 30, 2021 | Aug 31, 2021 | May 31, 2021 | Feb 28, 2021 | Nov 30, 2020 |
Net Income | -11.41M | -9.4M | -7.33M | -5.81M | -4.87M | -5.47M | -6.13M | -6.71M | -6.98M | -7.01M | -7.15M | -7.38M | -7.2M | -7.34M | -5.48M | -4.19M | -3.63M | -2.46M | -3.87M |
Depreciation & Amortization | 58.67K | 42.79K | 56.44K | 52.02K | 130.71K | 140.65K | 149.44K | 145.4K | 137.8K | 136.68K | 138.12K | 141.31K | 141.79K | 145.83K | 147.6K | 147.6K | 112.66K | 112.81K | 113.17K |
Stock-Based Compensation | 833.28K | 704.92K | 429.79K | 384.33K | 297.45K | 37.13K | 155.56K | 170.38K | 393.62K | 423.35K | 712.82K | 1.05M | 904.72K | 1.14M | 854.66K | 495.01K | 510.01K | 848.6K | 1.13M |
Other Working Capital | 127.92K | -567.85K | 586.04K | 121.25K | 65.08K | -116.76K | -57.76K | -14.84K | -506.04K | -113.75K | -23.12K | -262.73K | 38.59K | -48.33K | -215.13K | -234.89K | -109.46K | -77.13K | 70.11K |
Other Non-Cash Items | 640.97K | 1.02M | 48.66K | 34.53K | 7.63K | -61.86K | 48.03K | 134.63K | 628.8K | 1.47M | 1.7M | 1.62M | 1.28M | 431.3K | 188.08K | 185.86K | 90.79K | 179.82K | 169.95K |
Deferred Income Tax | n/a | n/a | n/a | 53.22K | 303.89K | 302.04K | 302.04K | 248.82K | -1.86K | n/a | n/a | 340.31K | 340.31K | 1.2M | -259.75K | -610.52K | -610.52K | -1.41M | 46.32K |
Change in Working Capital | 174.13K | 250.45K | 81.92K | 115.52K | -773.46K | -369.75K | -344.4K | 143.26K | 393.34K | 84.05K | -47.79K | -351.48K | 135.74K | 127.15K | 296.21K | 63.53K | 37.83K | -214.03K | -313.97K |
Operating Cash Flow | -9.7M | -7.38M | -6.5M | -4.96M | -4.69M | -5.21M | -5.82M | -5.87M | -5.42M | -4.9M | -4.95M | -4.88M | -4.78M | -4.69M | -4.34M | -3.99M | -3.59M | -3.04M | -2.83M |
Capital Expenditures | -69.59K | -91.59K | -148.58K | -188.6K | -187.46K | -199.1K | -174.79K | -169.61K | -151.21K | -155.52K | -157.26K | -180.64K | -130.59K | -163.37K | -131.93K | -79.49K | -93.13K | -36.7K | -33.71K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2 | -2 | 273.37K | 273.37K | 273.38K | 273.38K | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 6.8K | 6.8K | 6.8K |
Other Investing Acitivies | -111.71K | -92.27K | -121.37K | -123.59K | -165.45K | -199.1K | -161.55K | -135.86K | -67.43K | -71.74K | -86.73K | -88.22K | -88.22K | -120.99K | 186.81K | 196.87K | 190.07K | 267.6K | -5.78K |
Investing Cash Flow | -154.73K | -157.29K | -186.38K | -188.6K | -187.46K | -199.1K | -174.79K | -169.61K | -151.22K | -155.53K | -157.27K | -180.64K | -130.6K | -163.37K | 141.44K | 193.88K | 180.24K | 243.48K | -26.91K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | 11.2K | 11.2K | 11.2K | n/a | -22.41K | -22.41K | -21.99K | -21.77K | -33.73K | -42.5K | -41K | -1.26K | 21.9K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 1.69M | 5.04M | 5.53M | 6.11M | 6.11M | 1.06M | 560.45K | -22.41K | -33.61K | -33.61K | -22.41K | -22.19K | 3.96M | 3.96M | 3.95M | 3.96M | -13.21K | 1.87M | 1.89M |
Financial Cash Flow | 6.05M | 9.4M | 12.84M | 10.32M | 10.19M | 6.86M | 3.41M | 1.58M | 1.69M | -33.61K | -44.82K | -44.6K | 3.94M | 3.94M | 13.4M | 13.4M | 9.38M | 11.31M | 1.98M |
Net Cash Flow | -3.87M | 1.76M | 6.12M | 5.15M | 5.3M | 1.43M | -2.58M | -4.46M | -3.89M | -5.09M | -5.15M | -5.1M | -1.06M | -987.56K | 9.16M | 9.62M | 6.07M | 8.61M | -807.98K |
Free Cash Flow | -9.77M | -7.47M | -6.65M | -5.15M | -4.88M | -5.41M | -5.99M | -6.04M | -5.58M | -5.05M | -5.1M | -5.06M | -4.91M | -4.85M | -4.47M | -4.07M | -3.69M | -3.08M | -2.86M |